Effect of MAPK/NF-κB signaling pathway on extracellular release of HMGB1induced by hypoxia in laryngeal Hep-2carcinoma cells
Le Li
Abstract
Le Li
Abstract
Objective:To investigate the extracellular release of high mobility group box 1(HMGB1)in laryngeal Hep-2carcinoma cells induced by hypoxia and its possible mechanism.Method:The changes of HMGB1concentration in the culture medium as well as HMGB1protein and mRNA expression in Hep-2cells were investigated after the cells were cultured with 1% O2for different durations.Inhibitory effects of MAPK pathway inhibitors(PD98059,SP600125,and SB202190)and nuclear NF-κB pathway inhibitor(PDTC)with various concentrations on extracellular HMGB1release were observed in hypoxia-induced Hep-2cells.The HMGB1concentration and HMGB1protein expression were measured by enzyme-linked immunosorbent assay(ELISA)and western blot,respectively.The HMGB1mRNA expression was determined by real-time quantitative PCR(RT-PCR).Result:The HMGB1concentration in the culture medium and the HMGB1protein expression in Hep-2cells increased after the cells were subjected to hypoxia culture for 12hin a time-dependent manner.The level of HMGB1mRNA expression in Hep-2cells increased after the cells were induced by hypoxia for 6hPD98059and SP600125with 20μmol/L and PDTC with 50mg/L partly inhibited extracellular release of HMGB1in hypoxia-cultured Hep-2cells.Conclusion:Hypoxia induces laryngeal carcinoma cells to release HMGB1,which may be related to MAPK/NF-κB signaling pathway.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the extracellular release of high mobility group box 1(HMGB1)in laryngeal Hep-2carcinoma cells induced by hypoxia and its possible mechanism.Method:The changes of HMGB1concentration in the culture medium as well as HMGB1protein and mRNA expression in Hep-2cells were investigated after the cells were cultured with 1% O2for different durations.Inhibitory effects of MAPK pathway inhibitors(PD98059,SP600125,and SB202190)and nuclear NF-κB pathway inhibitor(PDTC)with various concentrations on extracellular HMGB1release were observed in hypoxia-induced Hep-2cells.The HMGB1concentration and HMGB1protein expression were measured by enzyme-linked immunosorbent assay(ELISA)and western blot,respectively.The HMGB1mRNA expression was determined by real-time quantitative PCR(RT-PCR).Result:The HMGB1concentration in the culture medium and the HMGB1protein expression in Hep-2cells increased after the cells were subjected to hypoxia culture for 12hin a time-dependent manner.The level of HMGB1mRNA expression in Hep-2cells increased after the cells were induced by hypoxia for 6hPD98059and SP600125with 20μmol/L and PDTC with 50mg/L partly inhibited extracellular release of HMGB1in hypoxia-cultured Hep-2cells.Conclusion:Hypoxia induces laryngeal carcinoma cells to release HMGB1,which may be related to MAPK/NF-κB signaling pathway.
Key concepts: Extracellular, MAPK/ERK pathway, Hypoxia (environmental), Western blot, Signal transduction, HMGB1, Cell culture, Molecular biology